DI
TPTX

Disciplined Investments’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Disciplined Investments’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2
Closed – – 1728
2022
Q1 		$0 Buy
+2
New +$67 ﹤0.01% 1697

Other funds holding TPTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Disciplined Investments's TPTX Position: Q2 2022 in Review

Disciplined Investments sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2022, closing a stake of 2 shares.

Disciplined Investments first reported a position in TPTX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 208 funds tracked by Wall St. Rank hold TPTX as of Q2 2022.

  • Disciplined Investments reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Disciplined Investments sold 2 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2022.
  • Disciplined Investments first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Disciplined Investments's Turning Point Therapeutics, Inc. Common Stock position peaked at $0 in Q1 2022.
  • 208 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Disciplined Investments's 13F filing for Q2 2022, filed 9 Aug 2022.